Reliance Industries Limited has acquired a 100% stake in oncology platform Karkinos Healthcare, bolstering its digital and diagnostic healthcare services. The move is part of the conglomerate's broader strategy to integrate healthcare systems,

Reliance Industries, through its subsidiary RSBVL, has acquired the oncology-focused platform Karkinos for Rs 375 crore. Karkinos provides technology-driven cancer care solutions and aims to offer affordable end-to-end services.

Reliance Industries (RIL) shares will remain in focus on Monday after the company on Saturday announced the acquisition of technology-led oncology platform Karkinos Healthcare for Rs 375 crore, through its wholly-owned subsidiary Reliance Strategic Business Ventures (RSBVL),

Reliance Industries Limited (RELIANCE.NS) closed at ₹1221.65 as of December 30, 2024. This is 0.0491% or ₹0.6 above the previous close price of ₹1221.05. In rec

RIL said that Karkinos has canceled the existing outstanding 30,075 equity shares held by the erstwhile shareholders of Karkinos in accordance with the approved resolution plan."P